FIELD: medicine.
SUBSTANCE: present group of inventions refers to therapy of various diseases caused by reduced level of ATP. That is ensured by administering a combination of febuxostat and inosine.
EFFECT: this provides effective increase of intracellular ATP level due to synergetic action of the components of the combination.
8 cl, 10 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC OR PREVENTIVE AGENT FOR TUMOUR LYSIS SYNDROME | 2013 |
|
RU2627591C2 |
| COMBINED USE OF COMPOUND A AND COMPOUND B FOR PRODUCTION OF DRUGS FOR TREATMENT OF GOUT OR HYPERURICEMIA | 2019 |
|
RU2783862C1 |
| METHODS FOR PRESERVING RENAL FUNCTION WITH USING XANTHINE OXIDOREDUCTASE | 2007 |
|
RU2508099C2 |
| METHODS AND COMPOSITIONS FOR TREATING HYPERURICEMIA AND METABOLIC DISORDERS ASSOCIATED WITH HYPERURICEMIA | 2012 |
|
RU2603050C2 |
| METHOD OF DETERMINING PURINES AND PYRIMIDINES IN HUMAN BIOLOGICAL FLUIDS | 2012 |
|
RU2620155C2 |
| METHOD FOR EVALUATING RISK OF PREGNANCY FAILURE | 2012 |
|
RU2586412C2 |
| THERAPEUTIC DRUG OR PREVENTIVE THERAPEUTIC AGENT FOR DIABETIC NEPHROPATHY | 2017 |
|
RU2735538C1 |
| METHOD FOR DIAGNOSIS OF RENAL DAMAGE IN SYSTEMIC LUPUS ERYTHEMATOSUS | 2017 |
|
RU2677325C1 |
| PROCESS FOR PREPARING INDOLYSINE DERIVATIVES | 0 |
|
SU993817A3 |
| MODIFIED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING FEBUXOSTAT | 2011 |
|
RU2602188C2 |
